Pathological Examination Market Gaining Momentum in Cancer and Chronic Disease Diagnosis | Top Companies 2025 - 3DHISTECH Ltd., NeoGenomics Laboratories

"Pathological Examination market is anticipated to grow at a promising CAGR during the forecast period 2024-2031" As per DataM intelligence research report

As per our analysis The Pathological Examination market is expanding rapidly with the rising need for accurate, early disease detection. Digital pathology and AI-powered analysis are transforming slide interpretation and diagnostics. Hospitals and diagnostic labs are embracing automation for faster, more reliable results. Cancer, infectious diseases, and chronic conditions are key drivers of testing demand. Emerging markets are boosting growth with improved healthcare access and screening programs. This market is becoming the backbone of modern, evidence-based medical decision-making.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/pathological-examination-market?sp

Pathological Examination Market Drivers:

The pathological examination market is driven by the increasing prevalence of chronic diseases and rising demand for early diagnosis. Growing awareness about preventive healthcare and regular screening is boosting test volumes. Technological advancements in digital pathology and automation are enhancing diagnostic speed and accuracy. The rise in cancer, infectious diseases, and lifestyle disorders supports continuous testing needs. Expanding healthcare infrastructure and access to diagnostic labs are contributing to market growth. Government initiatives promoting routine health checks further drive demand.

Market growth is fueled by the increasing adoption of advanced imaging and staining techniques in pathology labs. Integration of AI and machine learning in diagnostic workflows is improving precision and efficiency. The growing geriatric population, more prone to various diseases, is raising testing requirements. Investments in pathology lab expansion and equipment modernization are supporting the market. Rising demand from hospitals, clinics, and academic research centers also boosts usage. Collaborations between diagnostic firms and healthcare providers are accelerating innovation and accessibility.

Pathological Examination Market: Recent Industry Developments

✅In July 2025 BD announced the merger of its Biosciences & Diagnostic Solutions business with Waters Corporation in a $17.5 billion Reverse Morris Trust deal-expected to close by Q1 2026. The transaction will double Waters' total addressable market, boost recurring revenue, and target ~$345M in annual cost synergies by 2030. BD shareholders will own ~39% of the merged entity.

✅In June 2025 Thermo Fisher is reportedly exploring the sale of parts of its specialty diagnostics business, including its microbiology unit, for approximately USD 4 billion. The move follows its earlier acquisition of Solventum (for purification/filtration business) and aligns with recent restructuring efforts. No finalized divestment announced yet.

✅In May 2025 Labcorp announced the acquisition of select clinical and anatomic pathology assets from Incyte Diagnostics, including labs in Spokane, Tukwila, Richland (WA), and Missoula (MT). Incyte pathologists will remain engaged for professional interpretation while Labcorp handles tissue processing and slide preparation. Completion expected later in 2025.pril 2025 Sartorius announced it is acquiring MatTek Corporation (including Visikol Inc.) from BICO Group AB in a deal valued at USD 80 million. The acquisition is expected to close in Q2 2025, pending regulatory approvals

Strategic Players Driving the Pathological Examination Market Forward:

Major key players in the pathological examination market are 3DHISTECH Ltd., NeoGenomics Laboratories, Inc., F. Hoffmann-La Roche Ltd, Bio SB, Agilent Technologies, Inc., Quest Diagnostics Incorporated, Sonic Healthcare, Diapath S.p.A., BioGenex, Leica Biosystems

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pathological-examination-market?sp

Research Methodology:
The global Pathological Examination Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Pathological Examination Market:

♦By Test: Digital Pathology, Traditional Pathology

♦By Service: Anatomic Pathology, Surgical Pathology, Molecular Pathology, Cytopathology, Clinical Pathology, Others

♦By Application: Genetic Abnormalities, Neoplasm, Infections, Cardiovascular Diseases, Others

♦By End user: Hospitals, Research Institutes, Diagnostic Centers, Others

Regional Analysis for Pathological Examination Market:

The Pathological Examination market is growing globally due to rising chronic diseases and demand for early diagnostics. North America leads, especially the U.S., driven by advanced diagnostic technologies and strong healthcare infrastructure. Europe, including Germany, the U.K., and France, shows steady growth with widespread use of digital pathology. Asia-Pacific, led by China, India, and Japan, is rapidly expanding due to increasing healthcare access and rising cancer cases. South America, particularly Brazil and Argentina, is adopting modern pathology tools to improve diagnostic accuracy. The Middle East & Africa show emerging growth, supported by healthcare modernization and government screening initiatives.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pathological-examination-market?sp

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.